Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
Acute Lymphoblastic Leukaemia Subtype and Side-Effects from Treatment – Nationwide analysis of severe treatment-related toxicity in childhood leukaemia
Protocol ID
ASSET
Disease (Sub Disease)
Leukaemia
Diagnosis Stage
Previously treated
Location
NSW, VIC, WA, SA, NZ, TAS
Sponsor
Kids Cancer Alliance (KCA)
Trial Status
Open
Sites
The Children's Hospital at Westmead
John Hunter Children's Hospital
Monash Children's Hospital
Perth Children's Hospital
Sydney Children's Hospital
Royal Children's Hospital
Women's & Children's Hospital
Royal Hobart Hospital
Christchurch Hospital
Starship Hospital
Study Type
Registry
Phase
Not applicable
Age Eligibility
up to 18 years
Back to Registry
Study Title Acute Lymphoblastic Leukaemia Subtype and Side-Effects from Treatment – Nationwide analysis of severe treatment-related toxicity in childhood leukaemia
Protocol ID ASSET
Disease (Sub Disease) Leukaemia
Diagnosis Stage Previously treated
Location NSW / VIC / WA / SA / NZ / TAS
Sponsor Kids Cancer Alliance (KCA)
Links http://www.assetstudy.com.au/
Trial Status Open
Trial Open Date 20/08/2015
Sites The Children's Hospital at Westmead / John Hunter Children's Hospital / Monash Children's Hospital / Perth Children's Hospital / Sydney Children's Hospital / Royal Children's Hospital / Women's & Children's Hospital / Royal Hobart Hospital / Christchurch Hospital / Starship Hospital
Study Type Registry
Phase Not applicable
Age Eligibility up to 18 years